SCHEMBL9259858

SCHEMBL9259858

COC(=O)CS[C@@H]1CCCC[C@H]1Sc1cccc(OC)c1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 10/20 0.45
MTNR1B P49286 10/20 0.45
CTSK P43235 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
DDB1 Q16531 1/20 0.43
CRBN Q96SW2 1/20 0.43
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
POLB P06746 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9259854 1.00 MTNR1A (0.45) MTNR1AMTNR1BCTSKCYP1A2CYP3A4
SCHEMBL9264273 0.89 CYP1A2 (0.46) MTNR1AMTNR1BCTSKCYP1A2CYP3A4
SCHEMBL9264279 0.89 CYP1A2 (0.46) MTNR1AMTNR1BCTSKCYP1A2CYP3A4
SCHEMBL9259467 0.86 CTSK (0.41) CTSKDDB1CRBNNPC1RAB9A
SCHEMBL9263608 0.86 CTSK (0.41) CTSKCYP3A4CYP2C19DDB1CRBN
SCHEMBL9263612 0.86 CTSK (0.41) CTSKCYP3A4CYP2C19DDB1CRBN
SCHEMBL9259463 0.86 CTSK (0.41) CTSKDDB1CRBNNPC1RAB9A
SCHEMBL9261965 0.85 NPC1 (0.47) CTSKCYP1A2CYP3A4CYP2C19SMN1; SMN2
SCHEMBL9261958 0.85 NPC1 (0.47) CTSKCYP1A2CYP3A4CYP2C19SMN1; SMN2
SCHEMBL9259375 0.84 MAPT (0.46) MTNR1AMTNR1BCTSKCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5476944-A Inhibitors or stimulators of superoxide generation; may also inhibit cyclooxygenase and/or 5-lipoxygenase; useful in therapeutic or prophylactic treatment of disease conditions G. D. SEARLE & CO. (US) 1995-12-19 US disclosed
EP-0613463-A1 DERIVATIVES OF CYCLIC PHENOLIC THIOETHERS AS INHIBITORS OR STIMULATORS OF SUPEROXIDE GENERATION G.D. SEARLE & CO. (US) 1994-09-07 EP disclosed
WO-1993010087-A1 DERIVATIVES OF CYCLIC PHENOLIC THIOETHERS AS INHIBITORS OR STIMULATORS OF SUPEROXIDE GENERATION G.D. SEARLE & CO. (US) 1993-05-27 WO disclosed